ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas

SIMPLE SUMMARY: There is still no efficient systemic treatment for pleomorphic sarcomas. This study shows that 1/4 of them have an ATRX alteration that diminishes the immune response. This phenotype is related to the inhibition of mast cell recruitment upon ATRX alteration, which could be targeted t...

Descripción completa

Detalles Bibliográficos
Autores principales: Darmusey, Lucie, Pérot, Gaëlle, Thébault, Noémie, Le Guellec, Sophie, Desplat, Nelly, Gaston, Laëtitia, Delespaul, Lucile, Lesluyes, Tom, Darbo, Elodie, Gomez-Brouchet, Anne, Richard, Elodie, Baud, Jessica, Leroy, Laura, Coindre, Jean-Michel, Blay, Jean-Yves, Chibon, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124877/
https://www.ncbi.nlm.nih.gov/pubmed/33946962
http://dx.doi.org/10.3390/cancers13092151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124877/
https://www.ncbi.nlm.nih.gov/pubmed/33946962
http://dx.doi.org/10.3390/cancers13092151

Ejemplares similares